Fluorescent nanodiamonds as a relevant tag for the assessment of alum adjuvant particle biodisposition.

Abstract

BACKGROUND:

Aluminum oxyhydroxide (alum) is a crystalline compound widely used as an immunologic adjuvant of vaccines. Concerns linked to alum particles have emerged following recognition of their causative role in the so-called macrophagic myofasciitis (MMF) lesion in patients with myalgic encephalomyelitis, revealing an unexpectedly long-lasting biopersistence of alum within immune cells and a fundamental misconception of its biodisposition. Evidence that aluminum-coated particles phagocytozed in the injected muscle and its draining lymph nodes can disseminate within phagocytes throughout the body and slowly accumulate in the brain further suggested that alum safety should be evaluated in the long term. However, lack of specific staining makes difficult the assessment of low quantities of bona fide alum adjuvant particles in tissues.

METHODS:

We explored the feasibility of using fluorescent functionalized nanodiamonds (mfNDs) as a permanent label of alum (Alhydrogel(®)). mfNDs have a specific and perfectly photostable fluorescence based on the presence within the diamond lattice of nitrogen-vacancy centers (NV centers). As the NV center does not bleach, it allows the microspectrometric detection of mfNDs at very low levels and in the long-term. We thus developed fluorescent nanodiamonds functionalized by hyperbranched polyglycerol (mfNDs) allowing good coupling and stability of alum:mfNDs (AluDia) complexes. Specificities of AluDia complexes were comparable to the whole reference vaccine (anti-hepatitis B vaccine) in terms of particle size and zeta potential.

RESULTS:

In vivo, AluDia injection was followed by prompt phagocytosis and AluDia particles remained easily detectable by the specific signal of the fND particles in the injected muscle, draining lymph nodes, spleen, liver and brain. In vitro, mfNDs had low toxicity on THP-1 cells and AluDia showed cell toxicity similar to alum alone. Expectedly, AluDia elicited autophagy, and allowed highly specific detection of small amounts of alum in autophagosomes.

CONCLUSIONS:

The fluorescent nanodiamond technology is able to overcome the limitations of previously used organic fluorophores, thus appearing as a choice methodology for studying distribution, persistence and long-term neurotoxicity of alum adjuvants and beyond of other types of nanoparticles.

• Authors: Housam Eidi, Marie-Odile David, Guillemette Crépeaux, Laetitia Henry, Vandana Joshi, Marie-Hélène Berger, Mohamed Sennour, Josette Cadusseau, Romain K Gherardi, Patrick A Curmi
• Journal: BMC medicine (BMC Med) Vol. 13 Pg. 144 (Jun 17 2015) ISSN: 1741-7015 [Electronic] England
• PMID: 26082187 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Adjuvants, Immunologic
• Alum Compounds
• Fluorescent Dyes
• Nanodiamonds
• aluminum sulfate

Topics

• Adjuvants, Immunologic (adverse effects)
• Adult
• Alum Compounds (adverse effects)
• Fasciitis (chemically induced)
• Female
• Fluorescent Dyes (pharmacology)
• Humans
• Myositis (chemically induced)
• Nanodiamonds
• Staining and Labeling (methods)